In 2023, anti-infective medicine sales in Germany stood at $3.73 billion USD PPP. From 2024 to 2028, this market is forecasted to grow from $3.81 billion USD PPP to $4.14 billion USD PPP, showing a year-on-year increase of approximately 2.36% in 2024, 2.36% in 2025, 2.05% in 2026, 2.01% in 2027, and 1.97% in 2028. The compound annual growth rate (CAGR) over this period is projected at roughly 2.05%.
Future trends to watch for include:
- Potential impacts from advancements in biotechnology and personalized medicine.
- Changes in regulatory policies and health insurance coverages in Germany.
- The influence of global health events and antibiotic resistance initiatives.
- Technological innovations in drug delivery and development.
